1 FTSE 250 stock that could rally in 2024

Shares in Dr Martens are down 53% since the start of 2023. But Stephen Wright thinks the FTSE 250 stock is set for a recovery next year.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Silhouette of a bull standing on top of a landscape with the sun setting behind it

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The FTSE 250 has been fairly steady in 2023. That’s actually quite respectable, although shares in Dr Martens (LSE:DOCS) have managed to lose around half their market value.

The reason is straightforward – the last 18 months or so have been an almost unmitigated disaster. But there are signs the worst could be in for the company and the stock might be set for a 2024 recovery. 

Profit warnings

How many profit warnings add up to a disaster? Management at Dr Martens has had five in six quarters, before withdrawing earnings guidance and growth targets entirely for next year.

This comes after the company announced a 17% decline in global revenues, led by a 22% drop in US sales. Management also announced it anticipates further declines in 2024.

Obviously, none of that is positive. But while optimistic shareholders have been hoping for a change of fortunes for some time now, I think a recovery might be on the cards even as the stock continues to hit new lows. 

Analysts predict a recovery

There are three reasons I think this could be a good time to buy the shares. The first is that every analyst price target I’ve seen for the stock in 2024 is higher than its current share price.

That’s very unusual and it might be that some analysts haven’t yet factored in the latest bad news. I think it’s a good sign of a rally to come, but it’s not my main reason for owning the stock.

More importantly, I think the market might be underestimating the outlook for the business. And this undue pessimism could be creating a long-term investment opportunity.

The US economy

Management attributed the firm’s struggles in the US to a difficult macroeconomic environment. But it has endured self-inflicted warehouse issues too. Yet it’s worth noting that the outlook for the US has been improving sharply in recent weeks.

Specifically, investors have started to become optimistic about the prospect of interest rate cuts in 2024. If these boost growth, Dr Martens could find demand improving quickly.

There were already signs of this in some strong Black Friday sales last month. But the share price doesn’t seem to be reflecting this for now, which is another reason I’m bullish.

Buybacks

The third reason I’m positive on this stock is the recent share buyback programme. Management has been making the most of a depressed share price to repurchase shares at low prices.

This stands out to me as an intelligent use of capital. It’s the kind of thing that can generate long-term value for shareholders even while the business is faced with a downturn.

Of course, if revenues and profits stay depressed, this can’t go on forever. But I think it’s a good decision from management while the opportunity is there.

Is this the FTSE 250’s biggest bargain?

Earnings projections are for the company to make 9p per share in 2024, rising to 10p in 2025. That makes the current share price of around 90p look cheap to me.

Given that I think the company’s fortunes in the US might improve more quickly than anticipated, I believe this stock could rally. I started buying it this month and I expect to keep buying in 2024.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Stephen Wright has positions in Dr. Martens Plc. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

US Stock

Here are the best-performing S&P 500 stocks after the US election result

Jon Smith notes some of the largest gainers from the S&P 500 yesterday and explains how the election result has…

Read more »

Growth Shares

2 UK stocks knocking on the door of promotion to the FTSE 100

Jon Smith points out a couple of UK stocks that he feels could be ready for the big league based…

Read more »

Investing Articles

Rolls-Royce shares just fell 7%. Is it time to buy?

This investor in Rolls-Royce shares takes a look at the FTSE 100 engine maker's trading update to see what caused…

Read more »

Young Black woman looking concerned while in front of her laptop
Investing Articles

What’s going on with the Auto Trader share price?

Paul Summers takes a closer look at why the Auto Trader share price has tumbled despite the company posting higher…

Read more »

Investing Articles

Legal & General shares look set to give me a mind-blowing 10.22% yield in 2026!

Harvey Jones is getting a brilliant second income from his Legal & General shares and expects even more to come.…

Read more »

Investing Articles

I’d consider this beaten-down FTSE 100 dividend stock to target a second income of £19,000

Our writer sees an opportunity to earn a substantial second income by investing in this UK insurance giant. Here’s his…

Read more »

Investing Articles

How cheap is the 72p Vodafone share price?

The Vodafone share price looks very cheap having fallen to a 72p price tag. But is it really the bargain…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Up 43% in a year and the IAG share price could keep on rising!

One of the FTSE 100’s highest-flying stocks still looks cheap on an earnings basis. Is this a brilliant buy for…

Read more »